Association between vitamin D supplementation and mortality: systematic review and meta-analysis
暂无分享,去创建一个
Yu Zhang | P. Xu | Fang Fang | Jingjing Tang | L. Jia | A. Faramand | Yuning Feng
[1] Cochrane Handbook for Systematic Reviews of Interventions Edited by Julian P. T. Higgins & , 2006 .
[2] J. Manson,et al. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] J. Manson,et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease , 2019, The New England journal of medicine.
[4] L. Ragolia,et al. Cognition and Vitamin D in Older African‐American Women– Physical performance and Osteoporosis prevention with vitamin D in older African Americans Trial and Dementia , 2018, Journal of the American Geriatrics Society.
[5] M. Urashima,et al. Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial , 2018, Clinical Cancer Research.
[6] A. Avenell,et al. Cancer and vitamin D supplementation: a systematic review and meta-analysis. , 2018, The American journal of clinical nutrition.
[7] P. Autier,et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. , 2017, The lancet. Diabetes & endocrinology.
[8] C. Camargo,et al. Effect of monthly high‐dose vitamin D on bone density in community‐dwelling older adults substudy of a randomized controlled trial , 2017, Journal of internal medicine.
[9] J. Gummert,et al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily , 2017, European heart journal.
[10] Kay-Tee Khaw,et al. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial , 2017, JAMA cardiology.
[11] C. Sempos,et al. The Reverse J-Shaped Association Between Serum Total 25-Hydroxyvitamin D Concentration and All-Cause Mortality: The Impact of Assay Standardization , 2017, American journal of epidemiology.
[12] S. Lanham-New,et al. Vitamin D deficiency as a public health issue: using vitamin D2 or vitamin D3 in future fortification strategies , 2017, Proceedings of the Nutrition Society.
[13] Vilmundur Gudnason,et al. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium , 2017, PloS one.
[14] O. Gómez-Marín,et al. Vitamin D and Physical Function in Sedentary Older Men , 2017, Journal of the American Geriatrics Society.
[15] J. Emberson,et al. Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care , 2016, Osteoporosis International.
[16] C. Cooper,et al. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. , 2016, Osteoarthritis and cartilage.
[17] S. Plein,et al. Effects of Vitamin D on Cardiac Function in Patients With Chronic HF , 2016, Journal of the American College of Cardiology.
[18] F. Cicuttini,et al. Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial. , 2016, JAMA.
[19] I. Njølstad,et al. Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.
[20] Thomas J. Wang. Vitamin D and Cardiovascular Disease. , 2016, Annual review of medicine.
[21] Elizabeth L. Barry,et al. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. , 2015, The New England journal of medicine.
[22] R. E. Johnson,et al. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial. , 2015, JAMA internal medicine.
[23] P. Kannus,et al. Exercise and vitamin D in fall prevention among older women: a randomized clinical trial. , 2015, JAMA internal medicine.
[24] David A. Jolliffe,et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. , 2015, The Lancet. Respiratory medicine.
[25] K. Wissing,et al. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] J. Wetterslev,et al. Vitamin D supplementation for prevention of cancer in adults. , 2014, The Cochrane database of systematic reviews.
[27] E. Giovannucci,et al. Vitamin D supplements and cancer incidence and mortality: a meta-analysis , 2014, British Journal of Cancer.
[28] O. Franco,et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies , 2014, BMJ : British Medical Journal.
[29] I. Reid,et al. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. , 2014, The lancet. Diabetes & endocrinology.
[30] J. Reginster,et al. Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients. , 2014, European journal of endocrinology.
[31] J. Wetterslev,et al. Vitamin D supplementation for prevention of mortality in adults. , 2011, The Cochrane database of systematic reviews.
[32] H. Brenner,et al. Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. , 2013, Preventive medicine.
[33] P. Donnan,et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. , 2013, JAMA internal medicine.
[34] Elina Hyppönen,et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis , 2012, The American journal of clinical nutrition.
[35] K. Zhu,et al. Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self‐reporting in randomized controlled trials of calcium supplementation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] J. Kanis,et al. Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden , 2012, Osteoporosis International.
[37] C. Cooper,et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). , 2012, The Journal of clinical endocrinology and metabolism.
[38] M. Decramer,et al. High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease , 2012, Annals of Internal Medicine.
[39] P. Glendenning,et al. Effects of three‐monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: A randomized controlled trial , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] R. Jorde,et al. Vitamin D, Insulin Secretion, Sensitivity, and Lipids , 2011, Diabetes.
[41] A. Avenell,et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis , 2011, BMJ : British Medical Journal.
[42] B. Roos,et al. The Response of Elderly Veterans to Daily Vitamin D3 Supplementation of 2,000 IU: A Pilot Efficacy Study , 2011, Journal of the American Geriatrics Society.
[43] B. Horne,et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. , 2010, The American journal of cardiology.
[44] A. Avenell,et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis , 2010, BMJ : British Medical Journal.
[45] H. Brenner,et al. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. , 2010, American heart journal.
[46] J. Simpson,et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.
[47] D. Papanicolaou,et al. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. , 2010, The American journal of clinical nutrition.
[48] M. Mcmurdo,et al. The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Patients With Heart Failure: A Randomized Controlled Trial , 2010, Circulation. Heart failure.
[49] M. Samson,et al. Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation , 2010, Aging clinical and experimental research.
[50] K. Thorlund,et al. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. , 2008, Journal of clinical epidemiology.
[51] J. Reginster,et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women , 2008, Osteoporosis International.
[52] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[53] K. Zhu,et al. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. , 2008, The Journal of clinical endocrinology and metabolism.
[54] F. Richy,et al. Differential Effects of D-Hormone Analogs and Native Vitamin D on the Risk of Falls: A Comparative Meta-Analysis , 2008, Calcified Tissue International.
[55] K. Zhu,et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. , 2008, Archives of internal medicine.
[56] F. Schmidt. Meta-Analysis , 2008 .
[57] C. Cooper,et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. , 2007, Rheumatology.
[58] J. Smit,et al. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents , 2007, Osteoporosis International.
[59] J. Potter,et al. Does vitamin D stop inpatients falling? A randomised controlled trial. , 2007, Age and ageing.
[60] R. Recker,et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.
[61] R. Newcombe,et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation , 2007, Osteoporosis International.
[62] D. Kiel,et al. A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study , 2007, Journal of the American Geriatrics Society.
[63] M. Law,et al. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. , 2006, Age and ageing.
[64] G. Tenderich,et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.
[65] J. Hopper,et al. Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trial , 2005, Journal of the American Geriatrics Society.
[66] J. Iwamoto,et al. Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial , 2005, Cerebrovascular Diseases.
[67] J. Aloia,et al. A randomized controlled trial of vitamin D3 supplementation in African American women. , 2005, Archives of internal medicine.
[68] H. Bischoff,et al. Alfacalcidol Reduces the Number of Fallers in a Community‐Dwelling Elderly Population with a Minimum Calcium Intake of More Than 500 Mg Daily , 2004, Journal of the American Geriatrics Society.
[69] G. Figtree,et al. Vitamin D supplementation and bone mineral density in early postmenopausal women. , 2003, The American journal of clinical nutrition.
[70] R. Doll,et al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.
[71] Anne Moseley,et al. A Randomized, Controlled Trial of Quadriceps Resistance Exercise and Vitamin D in Frail Older People: The Frailty Interventions Trial in Elderly Subjects (FITNESS) , 2003, Journal of the American Geriatrics Society.
[72] R. Lew,et al. Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[73] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[74] J. I. Pedersen,et al. Can Vitamin D Supplementation Reduce the Risk of Fracture in the Elderly? A Randomized Controlled Trial , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[75] S. Fowler,et al. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. , 2001, The Journal of clinical endocrinology and metabolism.
[76] K. Oizumi,et al. Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. , 1999, American journal of physical medicine & rehabilitation.
[77] Yoshihiro Sato,et al. Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[78] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[79] Yoshihiro Sato,et al. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. , 1997, Stroke.
[80] L. Bouter,et al. Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.
[81] L. Bouter,et al. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. , 1995, The Journal of clinical endocrinology and metabolism.
[82] Suzanne G. Leveille,et al. 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial. , 1991, The Journal of clinical endocrinology and metabolism.
[83] S. Ott,et al. Calcitriol treatment is not effective in postmenopausal osteoporosis. , 1989, Annals of internal medicine.
[84] J. Burton. The House Call , 1985, Journal of the American Geriatrics Society.
[85] R. Cohen,et al. Do vitamin D supplements improve the physical capabilities of elderly hospital patients? , 1985, Age and ageing.
[86] S. Pilz,et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. , 2012, The American journal of clinical nutrition.
[87] S. Lanham-New,et al. Comparison of vitamin D 2 and vitamin D 3 supplementation in raising serum 25-hydroxyvitamin D status : a systematic review and meta-analysis 1 – 3 , 2012 .
[88] S. Yusuf,et al. Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial , 2011, Diabetologia.
[89] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions : Explanation and Elaboration , 2009 .
[90] R. Harwood,et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. , 2004, Age and ageing.
[91] Suzanne G. Leveille,et al. 1,25-Dihydroxyvitamin D 3 and Muscle Strength in the Elderly: A Randomized Controlled Trial* , 1991 .
[92] G. Gothoni,et al. Calcium, vitamin D and anabolic steroid in treatment of aged bones: double-blind placebo-controlled long-term clinical trial. , 1983, Age and ageing.
[93] B. Jonson,et al. Effects of large doses of calciferol on patients with rheumatoid arthritis. A double-blind clinical trial. , 1973, Scandinavian journal of rheumatology.